Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapy
- 1 June 1999
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 35 (6), 921-927
- https://doi.org/10.1016/s0959-8049(99)00065-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Simultaneous Determination of Dihydrofluorouracil and 5-Fluorouracil in Plasma by High-Performance Liquid ChromatographyAnalytical Biochemistry, 1997
- Concurrent chemoradiation for oesophageal cancer: Factors influencing myelotoxicityAustralasian Radiology, 1996
- Factors influencing outcome following radio-chemotherapy for oesophageal cancerRadiotherapy and Oncology, 1996
- Combined modality therapy for esophageal carcinoma: Preliminary results from a large Australasian multicenter studyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- DNA damage and repair in telomeres: relation to aging.Proceedings of the National Academy of Sciences, 1995
- Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.Proceedings of the National Academy of Sciences, 1994
- Hematopoiesis in the aged: a model of hematopoietic dysregulation? [editorial; comment]Blood, 1993
- In vivo loss of telomeric repeats with age in humansMutation Research/DNAging, 1991
- Hematopoietic stem cells in elderly peopleMechanisms of Ageing and Development, 1986
- Normal Variations with Aging of the Amount of Hematopoietic Tissue in Bone Marrow from the Anterior Iliac Crest: A Study Made from 177 Cases of Sudden Death Examined by NecropsyAmerican Journal of Clinical Pathology, 1965